Aquestive Therapeutics (AQST) Inventory Average (2018 - 2026)

Aquestive Therapeutics' Inventory Average history runs 9 years deep, the most recent figure standing at $7.1 million for Q1 2026.

• In Q1 2026, Inventory Average rose 7.5% year-over-year to $7.1 million; the TTM figure through Mar 2026 stood at $7.1 million (up 7.5% YoY), while the FY2025 annual figure was $6.1 million, down 4.68% from the prior year.
• Inventory Average was $7.1 million for Q1 2026 at Aquestive Therapeutics, up from $7.0 million in the prior quarter.
• In the past five years, Inventory Average ranged from a high of $8.0 million in Q3 2025 to a low of $4.3 million in Q1 2022.
• Historically, Inventory Average has averaged $6.6 million across 5 years, with a median of $6.6 million in 2025.
• The sharpest annual moves came in 2022 and 2025: Inventory Average soared 105.77% in 2022, then declined 8.69% in 2025.
• A 5-year view of Inventory Average shows it stood at $6.3 million in 2022, then gained by 10.74% to $6.9 million in 2023, then retreated by 5.65% to $6.5 million in 2024, then gained by 7.56% to $7.0 million in 2025, then grew by 1.3% to $7.1 million in 2026.
• The last three Inventory Average figures came in at $7.1 million (Q1 2026), $7.0 million (Q4 2025), and $8.0 million (Q3 2025), per Business Quant data.